P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
Davide Capodanno, Usman Baber, Deepak L. Bhatt, Jean‐Philippe Collet, George Dangas, Francesco Franchi, C. Michael Gibson, Hyeon‐Cheol Gwon, Adnan Kastrati, Takeshi Kimura, Pedro A. Lemos, Renato D. Lópes, Roxana Mehran, Michelle L. O’Donoghue, Sunil V. Rao, Fabiana Rollini, Patrick Serruys, Philippe Gabríel Steg, Robert F. Storey, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Dominick J. Angiolillo
Topics & Concepts
MedicineP2Y12Percutaneous coronary interventionConventional PCIAspirinClopidogrelPharmacodynamicsAntithromboticGuidelineInternal medicineIntensive care medicineCardiologyMyocardial infarctionPharmacokineticsPathologyAntiplatelet Therapy and Cardiovascular DiseasesAtrial Fibrillation Management and OutcomesCoronary Interventions and Diagnostics